GALNT14 Antikörper (AA 34-639)

Produktnummer ABIN7874091

Der Kaninchen Polyklonal anti-GALNT14 Antikörper wird verwendet zum Nachweis von GALNT14 in Proben von Human, Maus und Ratte. Er wurde validiert für WB, ELISA, FACS, ICC und IF.

Kurzübersicht für GALNT14 Antikörper (AA 34-639) (ABIN7874091)

Target: GALNT14 (UDP-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 14 (GalNAc-T14) (GALNT14))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser GALNT14 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF)

Produktdetails anti-GALNT14 Antikörper

Bindungsspezifität: AA 34-639

Verwendungszweck: GALNT15 Antibody / Polypeptide N-acetylgalactosaminyltransferase 15

Aufreinigung: Immunogen affinity purified

Immunogen: E.coli-derived human GALNT15 recombinant protein (Position: H34-R639) was used as the immunogen for the GALNT15 antibody.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the GALNT15 antibody should be determined by the researcher.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: After reconstitution, the GALNT15 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Details zu GALNT14

Target: GALNT14 (UDP-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 14 (GalNAc-T14) (GALNT14))

Andere Bezeichnung: GALNT15

Hintergrund: GALNT15 antibody detects Polypeptide N-acetylgalactosaminyltransferase 15, encoded by the GALNT15 gene. Polypeptide N-acetylgalactosaminyltransferase 15 is a member of the GalNAc-transferase enzyme family that initiates O-linked glycosylation of proteins. GALNT15 antibody provides researchers with a specific reagent for studying protein glycosylation, cell surface biology, and disease mechanisms associated with altered glycan structures.

Polypeptide N-acetylgalactosaminyltransferase 15 catalyzes the first step in mucin-type O-glycosylation by transferring N-acetylgalactosamine to serine and threonine residues of proteins. Research using GALNT15 antibody has shown that it localizes to the Golgi apparatus, where it modifies a wide range of secreted and membrane proteins. This modification influences protein folding, stability, and interactions, highlighting its role in protein quality control.

Studies with GALNT15 antibody have revealed tissue-specific expression patterns, with high expression in reproductive tissues, brain, and gastrointestinal tract. This suggests specialized functions in mucosal barrier biology, fertility, and neuronal signaling. Isoform diversity further expands substrate specificity and biological functions of GALNT15.

Altered expression of GALNT15 has been implicated in cancer. Research using GALNT15 antibody has shown that abnormal glycosylation contributes to tumor progression by modifying adhesion molecules, receptors, and enzymes. Aberrant GALNT15 activity alters cell-cell communication and extracellular matrix interactions, promoting invasion and metastasis. These findings demonstrate its importance in tumor biology and potential as a biomarker.

In addition to cancer, variations in GALNT15 expression and function have been associated with infertility and neurological disease. Studies with GALNT15 antibody have suggested roles in sperm maturation and brain development. These findings expand its relevance beyond glycosylation to systemic physiology.

GALNT15 antibody is widely applied in western blotting, immunohistochemistry, and immunofluorescence. Western blotting quantifies isoforms and expression levels, immunohistochemistry identifies expression in tissue sections, and immunofluorescence demonstrates Golgi localization. These approaches make GALNT15 antibody essential for glycosylation research.

By supplying validated GALNT15 antibody reagents, NSJ Bioreagents supports studies into glycosylation, cancer, and reproductive biology. Detection of Polypeptide N-acetylgalactosaminyltransferase 15 provides researchers with insights into how glycan modification regulates protein function and disease mechanisms.

UniProt: Q8N3T1